Treatment
-
Q&A
Age Is More Than a NumberGeriatric oncologist Harvey Jay Cohen shines a spotlight on older people with cancer.
by Jocelyn Selim
-
Forward Look
A Diabetes Drug for Cancer?Lab results spur researchers to test low-cost medication on humans.
by Stephen Ornes
-
The Survival GapIn the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
-
Forward Look
The Avastin Roller CoasterUps and downs keep coming for Avastin as studies report on its effects for different cancers.
by Sue Rochman
-
Clinical Trials Game-Changer?A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?
by Sue Rochman
-
Cancer In America
Standard of CareResearch suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?
by Charlotte Huff
-
Forward Look
Boosting Defenses Against CancerQ&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.
by Ingfei Chen
-
Forward Look
Second-Cancer Clues?Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.
by Mitzi Baker
-
Forward Look
Getting PersonalHealth care experts push for care that focuses on the patient.
by Alanna Kennedy-Gorman
